HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials

Posted on by

PALO ALTO, Calif., Sept. 10, 2024 /PRNewswire/ — HepaTx, a biotechnology company specializing in regenerative medicine, has entered into a license agreement with Mayo Clinic to advance HepaTx’s innovative stem cell technology into clinical trials. This collaboration aims to develop and…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.